Moreover, C3 has shown an association with fibrin clot lysis in 837 type 2 diabetes individuals, while increased incorporation into fibrin networks of type 1 diabetes individuals suggests this protein may become a diabetes-specific target to improve hypofibrinolysis [110,111]. This evidence concerns the gene C3 and diabetes mellitus.